On this page
Back to topSolventum SOLV
Solventum is the 442nd largest S&P 500 company by market cap, worth $15.3 billion. Its board has 12 directors, 11 of them independent. 7 other officers are on file. At 30 Jun 2026, Vanguard was its largest institutional holder, with 10.0% of the company.
- CEO
- Bryan C. Hanson
- Chair
- Carrie Smith Cox
- Sector
- Health CareHealth Care Technology
- Headquarters
- Saint Paul, Minnesota
- Founded
- 2023
- Market cap
- $15.3B
- 442nd largest, 6 Nov 2026 close
- Price to sales
- 1.8
- Market cap over revenue
- Per employee
- $767K
- Market cap over employees
- Connections
- 8
- Companies sharing people
Financials
Latest quarter
Second Quarter 2026 figures from Solventum's earnings release.
Filed 5 Aug 2026
- Revenue
- $2.2B
- Up 2.2% year over year
- Net income
- $92M
- Up 2.2% year over year
- Diluted EPS
- $0.53
- Up 3.9% year over year
- Operating income
- $181M
- Down 15% year over year
Reported figures
Figures from the release, against the same period a year earlier.
| Figure | Value | Change |
|---|---|---|
| Net sales | $2.2B | +2.2% |
| Gross margin | 58.2% | +3.8 pts |
| Operating income | $181M | -15% |
| Operating income margin | 8.2% | -1.7 pts |
| Net income | $92M | +2.2% |
| Diluted earnings per share | $0.53 | +3.9% |
| Adjusted diluted earnings per share | $2.55 | +51% |
| Free cash flow | $144M | +144% |
| Net cash provided by operating activities | $227M | +34% |
| Adjusted operating income margin | 28.4% | +6.5 pts |
| Adjusted gross margin | 60.1% | +4.1 pts |
| Figure | Value | Change |
|---|---|---|
| Advanced Wound Care net sales | $537M | +15% |
| Infection Prevention and Surgical Solutions net sales | $836M | +11% |
| MedSurg net sales | $1.4B | +13% |
| Dental Solutions net sales | $396M | +17% |
| Health Information Systems net sales | $354M | +4.4% |
| All Other net sales | $87M | +12% |
| MedSurg operating income | $355M | +69% |
| Dental Solutions operating income | $131M | +37% |
| Health Information Systems operating income | $145M | +21% |
| All Other operating income | $19M | +138% |
| Figure | Value | Change |
|---|---|---|
| Organic sales growthFull-year 2026 outlook | 2.8% | - |
| Adjusted EPSFull-year 2026 outlook | $7.15 | - |
| Free cash flowFull-year 2026 outlook | $250M | - |
Financial history
Twelve months to 30 Sep 2026, from Solventum's quarterly filings.
Quarters since Mar 2023
- Revenue
- $8.2B
- Down 2.8% on the year before
- Net income
- $156M
- 1.9% of revenue
- Free cash flow
- $0
- Operating cash flow less capital spending
- P/E
- 98.3
- Market cap over net income
Quarterly results
Each quarter's revenue, net income and free cash flow.
Mar 2023 to Sep 2026
| Quarter | Revenue | Net income |
|---|---|---|
| Sep 2026 | $1.9B | $-12M |
| Jun 2026 | $2.2B | $92M |
| Mar 2026 | $2.0B | $13M |
| Dec 2025 | $2.0B | $63M |
| Sep 2025 | $2.1B | $1.3B |
| Jun 2025 | $2.2B | $90M |
| Mar 2025 | $2.1B | $137M |
| Dec 2024 | $2.1B | $31M |
| Sep 2024 | $2.1B | $122M |
| Jun 2024 | $2.1B | $89M |
| Mar 2024 | $2.0B | $237M |
| Dec 2023 | $2.0B | $272M |
| Sep 2023 | $2.1B | $460M |
| Jun 2023 | $2.1B | $321M |
| Mar 2023 | $2.0B | $293M |
Per employee
Twelve months to 30 Sep 2026, over 20,000 employees in Solventum's latest 10-K.
- Revenue
- $408K
- Operating profit
- $23K
- 5.6% of revenue
- Net income
- $8K
- 1.9% of revenue
Solventum's market cap since March 2024
Weekly, up to 6 Nov 2026
| Week ending | Market cap |
|---|---|
| 6 Nov 2026 | $15.3B |
| 26 Dec 2025 | $14.0B |
| 27 Dec 2024 | $11.5B |
Download Solventum's data as JSON, with the weekly market caps in billions of dollars from 29 Mar 2024.
Board and leadership
Board and officers
7 people here also hold roles at other S&P 500 companies.
Board from the proxy filed 27 Mar 2026; officers filed up to 30 Sep 2026
| Name | Title | Since | Independent | Committees | Age |
|---|---|---|---|---|---|
| Directors (12) | |||||
| Carrie Smith CoxChairIndependent · since 2024 · Talent, Science, Technology and QualityExecutive Chairman, Organon & Co.Also at Texas InstrumentsOther boards: Organon & Co. | |||||
| Bryan C. HansonChief Executive OfficerNot independent · since 2024 | |||||
| Carlos AlbanDirectorIndependent · since 2024 · Governance, TalentFormer Vice Chairman, Chief Commercial Officer, AbbVie Inc. | |||||
| Susan D. DeVoreDirectorIndependent · since 2024 · Governance (chair)Former Chief Executive Officer, Premier Inc.Also at Elevance HealthOther boards: Unum Group | |||||
| Shirley Ann EdwardsDirectorIndependent · since 2024 · Audit, TalentFormer Global Client Service Partner, Ernst & Young Global LimitedAlso at Baker HughesOther boards: Appian Corp. | |||||
| Glenn A. EisenbergDirectorIndependent · since 2024 · Audit (chair)Former EVP and CFO, Laboratory Corporation of America HoldingsOther boards: Middleby, MiniMed and Lumexa Imaging Holdings | |||||
| Bernard A. Harris Jr.DirectorIndependent · since 2024 · Governance, Science, Technology and QualityChief Executive Officer and Managing Partner, Versalius Ventures, Inc.Also at RTXOther boards: U.S. Physical Therapy | |||||
| Karen J. MayDirectorIndependent · since 2024 · Talent (chair)Former EVP and CHRO, Mondelez International, Inc.Other boards: Alcon | |||||
| Elizabeth MilyDirectorIndependent · since 2024 · Audit, Science, Technology and QualityChief Executive Officer, The T1D Fund | |||||
| John H. WeilandDirectorIndependent · since 2024 · Science, Technology and Quality (chair)Former President and COO, C.R. Bard, Inc. | |||||
| Amy McBride WendellDirectorIndependent · since 2024 · Governance, Science, Technology and QualityFormer SVP of Strategy and Business Development, Covidien plcAlso at Baxter InternationalOther boards: AxoGen and Hologic | |||||
| Darryl L. WilsonDirectorIndependent · since 2024 · Audit, TalentPresident, The Wilson CollectiveAlso at Eaton and NextEra EnergyOther boards: Primerica | |||||
| Officers (7) | |||||
| Wayde D. McMillanChief Financial OfficerLast filed 15 May 2026 | |||||
| Tammy L. GomezChief Human Resources OfficerLast filed 15 May 2026 | |||||
| Paul S. HarringtonChief Supply Chain OfficerLast filed 15 May 2026 | |||||
| Marcela A. KirbergerChief Legal Affairs OfficerLast filed 15 May 2026 | |||||
| Heather KnightChief Commercial OfficerAlso at WatersLast filed 9 Mar 2026 | |||||
| Amy LanducciChief Information OfficerLast filed 15 May 2026 | |||||
| Neil Craig ZieselmanSVP, Controller & CAOLast filed 18 Aug 2026 | |||||
Companies that share people with Solventum
Each person's title here, then at the other company.
- Baker Hughes BKR
- Shirley Ann Edwards: Director here, Director there
- Baxter International BAX
- Amy McBride Wendell: Director here, Director there
- Eaton ETN
- Darryl L. Wilson: Director here, Director there
- Elevance Health ELV
- Susan D. DeVore: Director here, Director there
- NextEra Energy NEE
- Darryl L. Wilson: Director here, Director there
- RTX RTX
- Bernard A. Harris Jr.: Director here, Director there
- Texas Instruments TXN
- Carrie Smith Cox: Chair here, Director there
- Waters WAT
- Heather Knight: Chief Commercial Officer here, Director there
Owners and trading
Largest institutional holders
Each fund group's share of Solventum. Where a company has several share classes, the share is of its total value.
13F filings for the quarter to 30 Jun 2026
Insider trades
Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.
Trades from 6 Nov 2025 to 6 Nov 2026
Directors and officers made no open-market sales and bought $100,344 in 1 purchase in the 12 months to 6 Nov 2026.
| Date | Person | Value |
|---|---|---|
| 10 Mar 2026Buy | Amy McBride WendellDirector | $100K |
Trades by members of Congress and officials
Trades members of Congress and senior executive branch officials disclosed, including their families'. Amounts are filed as ranges.
Trades from 27 Oct 2023 to 27 Oct 2026
8 people disclosed 12 purchases and 10 sales of Solventum stock since October 2023.
| Date | Member or official | Amount |
|---|---|---|
| 1 May 2026 | Rohit KhannaHouse, D-CA · Bought | $1K to $15K |
| 13 Apr 2026 | Rohit KhannaHouse, D-CA · Bought | $1K to $15K |
| 27 Mar 2026 | Alan ArmstrongSenate, R-OK · Bought | $1K to $15K |
| 26 Mar 2026 | Donald J TrumpPresident · Sold | $1K to $15K |
| 17 Mar 2026 | Donald J TrumpPresident · Sold | $1K to $15K |
| 12 Feb 2026 | Donald J TrumpPresident · Bought | $1K to $15K |
| 23 Jan 2026 | Rohit KhannaHouse, D-CA · Sold | $1K to $15K |
| 22 Jan 2026 | Rohit KhannaHouse, D-CA · Sold | $1K to $15K |
| 31 Dec 2025 | James French HillHouse, R-AR · Sold | $15K to $50K |
| 23 Dec 2025 | Rohit KhannaHouse, D-CA · Bought | $1K to $15K |
Showing 10 of 22 trades
Workforce and hiring
Workforce
Headcount at 31 Dec 2025
- Employees
- 20,000
Our employee base consists of approximately 20,000 employees, with approximately 40% having more than 10 years of tenure.
Timeline
Leadership changes, layoffs and insider sales
7 Nov 2024 to 7 Nov 2026; insider sales from 6 Nov 2025
2 departures and 2 appointments of directors and officers in the last two years.
Events, newest first
- 16 Jul 2026 Neil Zieselman appointedSenior Vice President, Controller and Chief Accounting Officer, effective 10 Aug 2026
- 20 Mar 2026 Mary Wilcox retiredChief Accounting Officer
- 17 Oct 2025 Chris Barry leftExecutive Vice President and Group President of MedSurg, effective 31 Dec 2025
- 17 Oct 2025 Heather Knight appointedChief Commercial Officer, effective 10 Nov 2025
| Date | Event | Filing |
|---|---|---|
| 16 Jul 2026 | Neil Zieselman appointedSenior Vice President, Controller and Chief Accounting Officer, effective 10 Aug 2026 | 8-K |
| 20 Mar 2026 | Mary Wilcox retiredChief Accounting Officer | 8-K |
| 17 Oct 2025 | Chris Barry leftExecutive Vice President and Group President of MedSurg, effective 31 Dec 2025 | 8-K |
| 17 Oct 2025 | Heather Knight appointedChief Commercial Officer, effective 10 Nov 2025 | 8-K |
Not on file: no WARN layoff notices under its own name or a listed subsidiary's since November 2023, no open roles from its careers site yet and no headcount history from earlier 10-Ks.